Dupilumab, an injectable interleukin (IL)-4 and IL-13 pathway inhibitor, recently received FDA approval as the first-ever ...

Early fall is when asthma flare-ups peak in the U.S., and a warming climate is bad news for sufferers: It means more ...

Two posters presented at the CHEST 2024 annual meeting underscore the importance of early identification and treatment of ...

This week, the FDA granted approval to Sanofi SNY and Regeneron’s REGN blockbuster drug, Dupixent, for its sixth indication.

Chronic obstructive pulmonary disease (COPD), an irreversible form of lung disease, is treated with prescription drugs, lifestyle changes, rehabilitation therapies, and surgery in certain cases. The ...

The data were obtained from October 1, 2019, to December 31, 2019. Participants were diagnosed with asthma or COPD and received inhaled maintenance therapy with the last available prescription in the ...

Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue. This leads to poor airflow ...

The U.S. Food and Drug Administration ... as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

Eli Lilly (NYSE:LLY) is reportedly looking to study its popular weight-loss drug Zepbound in people who aren't considered overweight but are still at risk for developing conditions such as diabetes.

However, the COPD segment is expected to see substantial growth due to advancements in treatment. By Medication Class: Key segments include combination drugs, inhaled corticosteroids (ICS), short ...